Cite
Toxic epidermal necrolysis versus cutaneous Graft-Versus-Host Disease in a hematopoietic stem cell transplant recipient: the role of elafin.
MLA
Chen, Alessandra, et al. “Toxic Epidermal Necrolysis versus Cutaneous Graft-Versus-Host Disease in a Hematopoietic Stem Cell Transplant Recipient: The Role of Elafin.” Leukemia & Lymphoma, vol. 59, no. 9, Sept. 2018, pp. 2261–63. EBSCOhost, https://doi.org/10.1080/10428194.2017.1422867.
APA
Chen, A., Chao, K., Worswick, S., Rodriguez, L., & Munday, W. (2018). Toxic epidermal necrolysis versus cutaneous Graft-Versus-Host Disease in a hematopoietic stem cell transplant recipient: the role of elafin. Leukemia & Lymphoma, 59(9), 2261–2263. https://doi.org/10.1080/10428194.2017.1422867
Chicago
Chen, Alessandra, Kevin Chao, Scott Worswick, Lina Rodriguez, and William Munday. 2018. “Toxic Epidermal Necrolysis versus Cutaneous Graft-Versus-Host Disease in a Hematopoietic Stem Cell Transplant Recipient: The Role of Elafin.” Leukemia & Lymphoma 59 (9): 2261–63. doi:10.1080/10428194.2017.1422867.